Sartorius AGSARTF -1.83%85 PEG Ratio is 20.27 as of Jun. 25, 2026, which is 537% above its 10-year median of 3.18. GuruFocus rates SARTF with a GF Score™ of 85/100 and a GF Value™ of $274.24 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 208 Medical Devices & Instruments companies, Sartorius AG ranks worse than 95.67% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Sartorius AG's PEG Ratio or its related term are showing as below:
SARTF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.82 Med: 3.18 Max: 73.24
Current: 20.27
During the past 13 years, Sartorius AG's highest PEG Ratio was 73.24. The lowest was 0.82. And the median was 3.18.
SARTF's PEG Ratio is ranked worse than 95.67% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.935
vs SARTF: 20.27
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Sartorius AG (OTCPK:SARTF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Sartorius AG PEG Ratio Related Terms
Sartorius AG PEG Ratio Historical Data
* Premium members only.
The historical data trend for Sartorius AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Sartorius AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sartorius AG PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Sartorius AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Sartorius AG (SARTF) has a PEG Ratio of 20.27 as of Jun. 25, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Sartorius AG and its competitors. This is 537% above median its historical median of 3.18. Over the past decade, Sartorius AG's PEG Ratio has ranged from 0.82 to 73.24. According to the industry distribution chart, Sartorius AG ranks #199 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 95.7%.
Is Sartorius AG's PEG Ratio too high?
Sartorius AG's current PEG Ratio of 20.27 is 537% above median its 10-year median of 3.18. Over the past 10 years, this metric has ranged from a low of 0.82 to a high of 73.24. The Medical Devices & Instruments industry median PEG Ratio is 1.94. Sartorius AG's value of 20.27 is 947.5% above this industry median. Based on the distribution chart, Sartorius AG ranks #199 out of 208 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sartorius AG has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius AG's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sartorius AG ranks #199 out of 208 companies for PEG Ratio. This places Sartorius AG in the lower half of its industry. The industry median PEG Ratio is 1.94. Sartorius AG's value of 20.27 is 947.5% above this benchmark. Historically, Sartorius AG's own PEG Ratio has ranged from 0.82 to 73.24 over the past decade. While the company's 10-year median is 3.18 vs. the industry median of 1.94, Sartorius AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.94, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sartorius AG's current PEG Ratio of 20.27 is 947.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Sartorius AG and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sartorius AG's current PEG Ratio is 20.27, which is 537% above median its own 10-year median of 3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius AG stock overvalued right now?
Based on GuruFocus' analysis, Sartorius AG (SARTF) is currently considered Significantly Undervalued. The stock's GF Value™ is $274.24, compared to a current price of $192.43 — trading 29.8% below its estimated fair value. The current PEG Ratio is 20.27, which is 537% above median its 10-year median of 3.18 and 947.5% above the Medical Devices & Instruments industry median of 1.94. Sartorius AG's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Sartorius AG (SARTF), the current PEG Ratio is 20.27 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sartorius AG (SARTF) Overvalued in 2026?
Based on GuruFocus' analysis, Sartorius AG stock appears to be undervalued.
The current stock price of $192.43 is trading 29.8% below its estimated GF Value™ of $274.24.
GuruFocus considers Sartorius AG to be Significantly Undervalued.
Key valuation signals for SARTF:
PEG Ratio: 20.27 (537% above median its 10-year median of 3.18)
GF Value™: $274.24 vs. price of $192.43 (29.8% below fair value)
Industry Position: 947.5% above the Medical Devices & Instruments median (#199 of 208)
No single metric tells the full story. See the SARTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs and focuses on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.
85GF Score
Get the complete analysis for SARTF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SARTF has been successfully added to your 
